Clinical Trial Update: GS-7977 With Ribavirin for Hepatitis C (SPARE) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 SPARE trial evaluating sofosbuvir with ribavirin for Hepatitis C completed, with results posted in September 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-09-26